Inflammatory protein profiling in immune cells identifies molecular signatures for enhanced diagnostic precision in psoriatic arthritis
Jesus Eduardo Martín-Salazar·Nuria Barbarroja·María Dolores López-Montilla·Laura Romero-Zurita·Carlos Pérez-Sánchez·Chary Lopez-Pedrera·Eduardo Collantes-Estévez·María Carmen Ábalos-Aguilera·Iván Arias-de la Rosa·María Ángeles Puche-Larrubia·Miriam Ruiz-Ponce·Clementina López-Medina·Antonio Manuel Barranco·Jerusalem Calvo·Pedro Ortiz-Buitrago·Alejandro Escudero-Contreras·Laura Cuesta-López·Adrian Santiago Ortiz·Elena Moreno-Caño·Rafaela Ortega
Psoriatic arthritis (PsA) lacks reliable biomarkers to support early diagnosis and disease stratification. This study aimed to identify protein signatures associated with PsA and develop a clinically relevant model integrating molecular and clinical features. We conducted a cross-sectional study including 143 patients with PsA and 101 controls across three cohorts. The exploratory cohort included 77 patients with PsA and 50 symptomatic controls without inflammatory disease. Two independent cohor
